269 related articles for article (PubMed ID: 18708358)
21. Angiomotin is a novel component of cadherin-11/β-catenin/p120 complex and is critical for cadherin-11-mediated cell migration.
Ortiz A; Lee YC; Yu G; Liu HC; Lin SC; Bilen MA; Cho H; Yu-Lee LY; Lin SH
FASEB J; 2015 Mar; 29(3):1080-91. PubMed ID: 25466890
[TBL] [Abstract][Full Text] [Related]
22. E-cadherin and beta-catenin are down-regulated in prostatic bone metastases.
Bryden AA; Hoyland JA; Freemont AJ; Clarke NW; Schembri Wismayer D; George NJ
BJU Int; 2002 Mar; 89(4):400-3. PubMed ID: 11872032
[TBL] [Abstract][Full Text] [Related]
23. A new model of multi-visceral and bone metastatic prostate cancer with perivascular niche targeting by a novel endothelial specific adenoviral vector.
Lu ZH; Kaliberov S; Sohn RE; Kaliberova L; Du Y; Prior JL; Leib DJ; Chauchereau A; Sehn JK; Curiel DT; Arbeit JM
Oncotarget; 2017 Feb; 8(7):12272-12289. PubMed ID: 28103576
[TBL] [Abstract][Full Text] [Related]
24. Cadherin-11 regulates the metastasis of Ewing sarcoma cells to bone.
Hatano M; Matsumoto Y; Fukushi J; Matsunobu T; Endo M; Okada S; Iura K; Kamura S; Fujiwara T; Iida K; Fujiwara Y; Nabeshima A; Yokoyama N; Fukushima S; Oda Y; Iwamoto Y
Clin Exp Metastasis; 2015 Aug; 32(6):579-91. PubMed ID: 26092671
[TBL] [Abstract][Full Text] [Related]
25. LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis.
Thalmann GN; Sikes RA; Wu TT; Degeorges A; Chang SM; Ozen M; Pathak S; Chung LW
Prostate; 2000 Jul; 44(2):91-103 Jul 1;44(2). PubMed ID: 10881018
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance.
Tanaka H; Kono E; Tran CP; Miyazaki H; Yamashiro J; Shimomura T; Fazli L; Wada R; Huang J; Vessella RL; An J; Horvath S; Gleave M; Rettig MB; Wainberg ZA; Reiter RE
Nat Med; 2010 Dec; 16(12):1414-20. PubMed ID: 21057494
[TBL] [Abstract][Full Text] [Related]
27. TWIST modulates prostate cancer cell-mediated bone cell activity and is upregulated by osteogenic induction.
Yuen HF; Kwok WK; Chan KK; Chua CW; Chan YP; Chu YY; Wong YC; Wang X; Chan KW
Carcinogenesis; 2008 Aug; 29(8):1509-18. PubMed ID: 18453541
[TBL] [Abstract][Full Text] [Related]
28. PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer.
Barber AG; Castillo-Martin M; Bonal DM; Jia AJ; Rybicki BA; Christiano AM; Cordon-Cardo C
Cancer Med; 2015 Aug; 4(8):1258-71. PubMed ID: 26033689
[TBL] [Abstract][Full Text] [Related]
29. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
[TBL] [Abstract][Full Text] [Related]
30. PKCε Is an Essential Mediator of Prostate Cancer Bone Metastasis.
Gutierrez-Uzquiza A; Lopez-Haber C; Jernigan DL; Fatatis A; Kazanietz MG
Mol Cancer Res; 2015 Sep; 13(9):1336-46. PubMed ID: 26023164
[TBL] [Abstract][Full Text] [Related]
31. Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines.
Wu TT; Sikes RA; Cui Q; Thalmann GN; Kao C; Murphy CF; Yang H; Zhau HE; Balian G; Chung LW
Int J Cancer; 1998 Sep; 77(6):887-94. PubMed ID: 9714059
[TBL] [Abstract][Full Text] [Related]
32. Skp2 and Slug Are Coexpressed in Aggressive Prostate Cancer and Inhibited by Neddylation Blockade.
Mickova A; Kharaishvili G; Kurfurstova D; Gachechiladze M; Kral M; Vacek O; Pokryvkova B; Mistrik M; Soucek K; Bouchal J
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799604
[TBL] [Abstract][Full Text] [Related]
33. Paradoxical expression of E-cadherin in prostatic bone metastases.
Bryden AA; Freemont AJ; Clarke NW; George NJ
BJU Int; 1999 Dec; 84(9):1032-4. PubMed ID: 10571629
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.
Nemeth JA; Yousif R; Herzog M; Che M; Upadhyay J; Shekarriz B; Bhagat S; Mullins C; Fridman R; Cher ML
J Natl Cancer Inst; 2002 Jan; 94(1):17-25. PubMed ID: 11773278
[TBL] [Abstract][Full Text] [Related]
35. ADAM15 supports prostate cancer metastasis by modulating tumor cell-endothelial cell interaction.
Najy AJ; Day KC; Day ML
Cancer Res; 2008 Feb; 68(4):1092-9. PubMed ID: 18281484
[TBL] [Abstract][Full Text] [Related]
36. MTA1 drives malignant progression and bone metastasis in prostate cancer.
Kumar A; Dhar S; Campanelli G; Butt NA; Schallheim JM; Gomez CR; Levenson AS
Mol Oncol; 2018 Sep; 12(9):1596-1607. PubMed ID: 30027683
[TBL] [Abstract][Full Text] [Related]
37. N-cadherin mediates angiogenesis by regulating monocyte chemoattractant protein-1 expression via PI3K/Akt signaling in prostate cancer cells.
Nalla AK; Estes N; Patel J; Rao JS
Exp Cell Res; 2011 Oct; 317(17):2512-21. PubMed ID: 21855541
[TBL] [Abstract][Full Text] [Related]
38. Expression of Cadherin-17 Promotes Metastasis in a Highly Bone Marrow Metastatic Murine Breast Cancer Model.
Okada T; Kurabayashi A; Akimitsu N; Furihata M
Biomed Res Int; 2017; 2017():8494286. PubMed ID: 28197418
[TBL] [Abstract][Full Text] [Related]
39. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
40. The role of S100A4 for bone metastasis in prostate cancer cells.
Kim B; Jung S; Kim H; Kwon JO; Song MK; Kim MK; Kim HJ; Kim HH
BMC Cancer; 2021 Feb; 21(1):137. PubMed ID: 33549040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
